EN
HI
Aurobindo Pharma share price chart
Aurobindo Pharma Share Key Metrics
Volume
5.74 L
Market Cap
94649.66 CR
LTQ@LTP
1@1645.00
ATP
1638.1
Var Margin
14.41 %
Circuit Range
1464.5-1789.9
Delivery %
42.53 %
Value
94.02 CR
ASM/GSM
No
Market Lot
1
Summary
AUROPHARMA stock price is ₹1645 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹1626.30 and ₹1645.90, while Aurobindo Pharma share price 52 week high low is ₹1016.10 & ₹1682.40.
In terms of trading activity, AUROPHARMA share price has recorded a volume of 5,73,961 shares. The Aurobindo Pharma has a market cap of ₹575377895. The stock’s Average Traded Price (ATP) stands at ₹1638.10, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1645.00.
The Aurobindo Pharma upper circuit limit is ₹1789.90 & The Aurobindo Pharma lower circuit limit is ₹1464.50, with a Value of ₹94.02 CR. The Delivery Percentage for the day is 42.53%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Aurobindo Pharma Fundamentals
P/E Ratio
25.18
P/B Ratio
2.4
Div. Yield
0.25
Sector P/E
63.29
Sector P/B
3.31
Sec. Div. Yield
0.51
Aurobindo Pharma Resistance and Support
Pivot 1632.37
Resistance
First Resistance
1646.84
Second Resistance
1666.47
Third Resistance
1680.94
Support
First Support
1612.74
Second Support
1598.27
Third Support
1578.64
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
25AUG26
1642.40
13.30 (0.82%)
29SEP26
1653.10
13.30 (0.81%)
27OCT26
1658.00
8.00 (0.48%)
AUROPHARMA|25AUG26 CE 1640.00
24.70
3.35 (15.69%)
AUROPHARMA|25AUG26 PE 1660.00
34.6
-8.15 (-19.06%)
Aurobindo Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 18 2026 | 1631 | 1645 | 1.09% | 1645.9 | 1626.3 |
| Mon Aug 17 2026 | 1630.59 | 1627.19 | 0.31% | 1652 | 1617.9 |
| Fri Aug 14 2026 | 1662.4 | 1622.09 | -2.48% | 1670 | 1621.9 |
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Classification Of US FDA Inspection At Raleigh Plant, North Carolina, Owned By Aurolife Pharma LLC, A Wholly Owned Step-Down Subsidiary Of The Company, As Voluntary Action Indicated (VAI)
Aurobindo Pharma's US subsidiary, Aurolife Pharma LLC, has received a "Voluntary Action Indicated" (VAI) classification for its Raleigh, North Carolina plant following a USFDA inspection. This closure allows pending product applications from the facility to advance through the FDA's review process.
Aug 17 2026 07:37:04
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aurobindo Pharma will engage with investors and analysts at the Motilal Oswal 22nd Annual Global Investor Conference on August 19, 2026. The company confirmed no unpublished price sensitive information will be discussed.
Aug 14 2026 16:31:22
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Lupin Ltd.
2232.00
-27.00 (1.20%)
Dr. Reddy's Laboratories Ltd.
1178.80
-13.20 (1.11%)
Mankind Pharma Ltd.
2380.00
-0.90 (0.04%)
Max Healthcare Institute Ltd.
1014.40
10.70 (1.07%)
Laurus Labs Ltd.
1814.00
4.30 (0.24%)
Manipal Health Enterprises Ltd.
724.80
1.90 (0.26%)
Aster DM Quality Care Ltd.
818.00
-1.75 (0.21%)
Fortis Healthcare Ltd.
916.70
7.95 (0.87%)
Biocon Ltd.
417.50
5.50 (1.33%)
Glenmark Pharmaceuticals Ltd.
2305.00
-24.00 (1.03%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1645 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.18. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.4. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 63.29 & 3.31 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 94649.66 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1682.40 & 1016.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade